Thursday, 29 January 2015

Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents

Post from http://www.danieluk.net

Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents

In the only randomized clinical trial I can find (poster available on the company"s Web site), the 28-day and 60-day mortality was the same for sepsis patients undergoing cytokine removal with Cytosorb compared to control sepsis patients. The mortality …
Read more on TheStreet.com


Williamson Girl Scouts honored for achievements

She designed and made an educational brochure and 100 cat scratchers for the local shelters to give away with adopted cats. Sheona Gozmao of Troop 2365 not … Troop 1360: Wendy Keiser, Briana O"Neil and Ashley Page. Project name: Stretch Classes for …
Read more on The Tennessean



Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents http://www.danieluk.net/news/biotech-stock-mailbag-small-cap-rebound-avanir-ohr-cytosorbents/ #Page, #WebSite

No comments:

Post a Comment